Mercer Global Advisors
STRO icon

Mercer Global Advisors’s Sutro Biopharma STRO Stock Holding History

Mercer Global Advisors’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.72K Buy
+112
New +$3.49K ﹤0.01% 5438

Other funds holding STRO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mercer Global Advisors's STRO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Sutro Biopharma (STRO) in Q2 2026: 112 shares worth $3.72K. The stake represents ﹤0.01% of the portfolio and ranks #5438 among its holdings.

55 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Mercer Global Advisors held 112 shares of Sutro Biopharma worth $3.72K as of Q2 2026.
  • Sutro Biopharma was a new Mercer Global Advisors position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5438 holding.
  • 55 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.